← FDA Drug Approvals (Drugs@FDA)
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2026-09-10
Drug application
- FDA Application #
ANDA220884- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
- Generic name
- Hydrochlorothiazide
- Active ingredients
- HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- First approval
- 2026-09-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown